These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8603019)

  • 1. Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy.
    Bokarewa MI; Bremme K; Blombäck M
    Br J Haematol; 1996 Feb; 92(2):473-8. PubMed ID: 8603019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial and venous thrombosis in two Italian families with the factor V Arg506-->Gln mutation.
    Montaruli B; Voorberg J; Tamponi G; Borchiellini A; Muleo G; Pannocchia A; van Mourik JA; Schinco P
    Eur J Haematol; 1996 Jul; 57(1):96-100. PubMed ID: 8698138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V gene mutation is a risk factor for cerebral venous thrombosis.
    Martinelli I; Landi G; Merati G; Cella R; Tosetto A; Mannucci PM
    Thromb Haemost; 1996 Mar; 75(3):393-4. PubMed ID: 8701395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
    Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E
    Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of resistance to activated protein C in the course of pregnancy and prevalence of factor V mutation.
    Mimuro S; Lahoud R; Beutler L; Trudinger B
    Aust N Z J Obstet Gynaecol; 1998 May; 38(2):200-4. PubMed ID: 9653861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.
    Voorberg J; Roelse J; Koopman R; Büller H; Berends F; ten Cate JW; Mertens K; van Mourik JA
    Lancet; 1994 Jun; 343(8912):1535-6. PubMed ID: 7911872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic risk factors and oral contraception.
    Bokarewa MI; Falk G; Sten-Linder M; Egberg N; Blombäck M; Bremme K
    J Lab Clin Med; 1995 Sep; 126(3):294-8. PubMed ID: 7665978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Arg506-->Gln mutation in patients with antiphospholipid antibodies.
    Montaruli B; Borchiellini A; Tamponi G; Giorda L; Bessone P; van Mourik JA; Voorberg J; Schinco P
    Lupus; 1996 Aug; 5(4):303-6. PubMed ID: 8869903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Zotz RB
    Thromb Haemost; 2003 Jul; 90(1):77-85. PubMed ID: 12876629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
    Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
    J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C resistance can be associated with recurrent fetal loss.
    Brenner B; Mandel H; Lanir N; Younis J; Rothbart H; Ohel G; Blumenfeld Z
    Br J Haematol; 1997 Jun; 97(3):551-4. PubMed ID: 9207398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
    Bergrem A; Dahm AE; Jacobsen AF; Mowinckel MC; Sandvik L; Sandset PM
    Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals.
    Zama T; Murata M; Ono F; Watanabe K; Watanabe R; Moriki T; Yokoyama K; Tokuhira M; Ikeda Y
    Int J Hematol; 1996 Dec; 65(1):71-8. PubMed ID: 8990627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
    Zöller B; Svensson PJ; He X; Dahlbäck B
    J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of resistance to activated protein C during pregnancy.
    Cumming AM; Tait RC; Fildes S; Yoong A; Keeney S; Hay CR
    Br J Haematol; 1995 Jul; 90(3):725-7. PubMed ID: 7647019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden in pregnancies complicated by placental abruption.
    Procházka M; Happach C; Marsál K; Dahlbäck B; Lindqvist PG
    BJOG; 2003 May; 110(5):462-6. PubMed ID: 12742330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting.
    Moor E; Silveira A; van't Hooft F; Tornvall P; Blombäck M; Wiman B; Rydén L; Hamsten A
    Thromb Haemost; 1998 Aug; 80(2):220-4. PubMed ID: 9716141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.
    Dahlbäck B
    Int J Lab Hematol; 2016 May; 38 Suppl 1():4-11. PubMed ID: 27161771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.